Cargando…
Drug resistance in leishmaniasis: Newer developments
Leishmaniasis is a vector borne protozoan disease and it remains a major public health problem world-wide. Lack of an effective vaccine and vector control program makes the chemotherapy as the primary tool for leishmaniasis. Antimonials were used as the first line of treatment for many years. Emerge...
Autor principal: | Mohapatra, Sarita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992802/ https://www.ncbi.nlm.nih.gov/pubmed/24754020 http://dx.doi.org/10.4103/2229-5070.129142 |
Ejemplares similares
-
Newer antithrombotic drugs
por: Sikka, Pranav, et al.
Publicado: (2010) -
Newer drug delivery systems in anesthesia
por: Dave, Sona, et al.
Publicado: (2017) -
Drug Resistance in Visceral Leishmaniasis
por: Maltezou, Helena C.
Publicado: (2010) -
Clozapine resistant schizophrenia: Newer avenues of management
por: Chakrabarti, Subho
Publicado: (2021) -
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
por: Krasowski, Matthew D.
Publicado: (2010)